老年人深静脉血栓治疗进展

doi:10.3969/j.issn.1003-9198.2025.09.001

摘要/Abstract

摘要： 随着人口老龄化加剧,老年人深静脉血栓(DVT)的发病率显著上升,已成为严重威胁老年人健康和生命的公共卫生问题。本文探讨了老年DVT的流行病学特征、高危因素及诊断流程,阐述了抗凝治疗、溶栓治疗、腔内治疗和压力治疗等不同治疗方法的适用情况、药物选择及注意事项。最后,本文提出在治疗过程中需综合考虑老年病人的生理特点、合并疾病及药物相互作用,以制定个体化的治疗方案,提高治疗效果,降低并发症发生率,改善老年病人的生活质量和预后。

关键词: 老年人, 深静脉血栓, 流行病学, 诊断, 治疗

Abstract: With the escalation of population aging, the incidence of deep vein thrombosis (DVT) in elderly patients has significantly increased, emerging as a public health issue that seriously threatens the health and life of the elderly. This paper explores the epidemiological characteristics, high-risk factors and diagnostic processes, and expounds on the applicable scenarios, drug selection, and precautions of different treatment methods, including anticoagulant therapy, thrombolytic therapy, endovascular treatment, and compression therapy. It is emphasized that during the treatment process, the physiological characteristics, comorbidities, and drug interactions of elderly patients should be comprehensively considered to formulate individualized treatment plans, so as to improve treatment efficacy, reduce the incidence of complications, and enhance the quality of life and prognosis of elderly patients.

Key words: aged, deep vein thrombosis, epidemiology, diagnosis, treatment

中图分类号:

R 543.6

王美娟, 姜学忠, 王屹. 老年人深静脉血栓治疗进展[J]. 实用老年医学, 2025, 39(9): 865-870.

WANG Meijuan, JIANG Xuezhong, WANG Yi. Advances in the treatment of deep vein thrombosis in the elderly[J]. Practical Geriatrics, 2025, 39(9): 865-870.

参考文献

[1] 曾保尧, 王斌强, 左江伟. 不同年龄和性别下肢深静脉血栓形成危险因素分析[J]. 中国现代医药杂志, 2020, 22(8): 12-18.
[2] NAESS I A, CHRISTIANSEN S C, ROMUNDSTAD P, et al. Incidence and mortality of venous thrombosis: a population-based study[J]. J Thromb Haemost, 2007, 5(4): 692-699.
[3] DELLUC A, TROMEUR C, LE VEN F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France[J]. Thromb Haemost, 2016, 116(5): 967-974.
[4] HEIT J A, ASHRANI A, CRUSAN D J, et al. Reasons for the persistent incidence of venous thromboembolism[J]. Thromb Haemost, 2017, 117(2): 390-400.
[5] 吴洲鹏, 李凤贺, 戴贻权, 等. 老年人静脉血栓栓塞症防治中国专家共识[J]. 中国普外基础与临床杂志, 2023, 30(10):1173-1187.
[6] MONREAL M, AGNELLI G, CHUANG L H, et al. Deep vein thrombosis in Europe-health-related quality of life and mortality[J]. Clin Appl Thromb Hemost, 2019, 25: 1076029619883946.
[7] BECKMAN M G, CRAIG HOOPER W, CRITCHLEY S E, et al. Venous thromboembolism: a public health concern[J]. Am J Prev Med, 2010, 38(4 Suppl): S495-S501.
[8] DINTENFASS L. Modifications of blood rheology during aging and age-related pathological conditions[J]. Aging: Milano, 1989, 1(2): 99-125.
[9] 马妍妍, 徐亚楠, 解华杰. 老年慢性阻塞性肺疾病急性加重期患者下肢深静脉血栓形成的危险因素分析[J]. 血管与腔内血管外科杂志, 2023,9(8): 917-921.
[10] KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) [J]. Eur Respir J, 2019, 54(3):1901647.
[11] YUAN J L, XIAO W K, ZHANG C Q, et al. Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients[J]. Heart Vessels, 2024, 39(7): 597-604.
[12] 孙葵葵, 王辰, 庞宝森, 等. 急性脑卒中住院患者深静脉血栓形成危险因素分析[J]. 中华流行病学杂志, 2004,25(12): 1019-1023.
[13] VARDI M, HARAN M. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score: a rebuttal[J]. J Thromb Haemost, 2011, 9(7): 1437-1438.
[14] CAPRINI J A. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2/3): 70-78.
[15] 王海军, 元钰鑫, 司全金, 等. 高龄卧床高危静脉血栓栓塞症防治中国专家共识[J]. 中华老年心脑血管病杂志, 2024, 26(12): 1381-1389.
[16] ESSAT M, GOODACRE S, PANDOR A, et al. Diagnostic accuracy of D-dimer for acute aortic syndromes: systematic review and meta-analysis[J]. Ann Emerg Med, 2024, 84(4): 409-421.
[17] BARRETT L, JONES T, HORNER D. The application of an age adjusted D-dimer threshold to rule out suspected venous thromboembolism (VTE) in an emergency department setting: a retrospective diagnostic cohort study[J]. BMC Emerg Med, 2022, 22(1): 186.
[18] 王琳, 刘洋, 陆再英. 2010年欧洲心脏病学会心房颤动处理指南解读[J]. 内科急危重症杂志, 2011, 17(2): 124-128.
[19] KAHN S R, LIM W, DUNN A S, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e195S-e226S.
[20] 中华医学会重症医学分会. 重症监护病房患者深静脉血栓形成预防指南[J]. 中国危重病急救医学, 2009, 21(9): 514-517.
[21] LAFAIE L, POENOU G, HANON O, et al. Anticoagulation and venous thromboembolism in patients aged 90 years and older: data from the RIETE registry[J]. J Am Geriatr Soc, 2024, 72(1): 113-125.
[22] RASCHKE R A, REILLY B M, GUIDRY J R, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial[J]. Ann Intern Med, 1993, 119(9): 874-881.
[23] 朱珠, 杨鸿溢, 陈安妮, 等. 抗凝药物在肝肾功能不全患者中的临床应用进展[J]. 中国医院药学杂志, 2018,38(4): 454-458.
[24] ERKENS P M, PRINS M H. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism[J]. Cochrane Database Syst Rev, 2010(9): CD001100.
[25] 刘晓辉, 宋景春, 张进华, 等. 中国抗血栓药物相关出血诊疗规范专家共识[J]. 解放军医学杂志, 2022,47(12): 1169-1179.
[26] SHENDRE A, PARMAR G M, DILLON C, et al. Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage[J]. Pharmacotherapy, 2018, 38(6): 588-596.
[27] ABSHER R K, ELISABETH MOORE M, PARKER M H. Patient-specific factors predictive of warfarin dosage requirements[J]. Ann Pharmacother, 2002, 36(10): 1512-1517.
[28] AGENO W, GALLUS A S, WITTKOWSKY A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e44S-e88S.
[29] 王乔宇, 武明芬, 柳鑫, 等. 2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南[J]. 中国临床药理学杂志, 2021,37(21): 2999-3016.
[30] AGNELLI G, BULLER H R, COHEN A, et al. Oral apixaban for the treatment of acute venous thromboembolism[J]. N Engl J Med, 2013, 369(9): 799-808.
[31] INVESTIGATORS H V, BÜLLER H R, DÉCOUSUS H, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013, 369(15): 1406-1415.
[32] PESSÔA R L, KESSLER V G, BECKER G G, et al. Efficacy and safety of direct oral anticoagulants for acute treatment of venous thromboembolism in older adults: a network meta-analysis of randomised controlled trials[J]. Vasc Endovascular Surg, 2024, 58(6): 633-639.
[33] 张馨丹. 新型口服抗凝药在心血管病中的研究进展[D]. 重庆: 重庆医科大学, 2016.
[34] 中国老年医学学会重症医学分会, 浙江省重症医学临床医学研究中心, 严静, 等. 老年重症患者静脉血栓栓塞症预防中国专家共识(2023)[J]. 中华危重病急救医学, 2023, 35(6): 561-572.
[35] 殷敏毅, 叶开创. 急性下肢深静脉血栓形成腔内治疗专家共识[J]. 血管与腔内血管外科杂志, 2023,9(5): 513-519.
[36] 顾建平, 徐克, 滕皋军. 下肢深静脉血栓形成介入治疗规范的专家共识(第2版)[J]. 介入放射学杂志, 2019, 28(1): 1-10.
[37] VEDANTHAM S, GOLDHABER S Z, JULIAN J A, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23): 2240-2252.
[38] CONG L, HUANG L, FAN B, et al. Analysis of the efficacy of angiojet percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in the treatment of subacute iliofemoral deep venous thrombosis in elderly patients[J]. Phlebology, 2025, 40(2): 88-94.
[39] TAKASE T, IWANAGA Y, YAMASHITA Y, et al. Long-term effects of non-retrieved inferior vena cava filters on recurrences of venous thromboembolism in cancer and non-cancer patients: from the COMMAND VTE registry[J]. Eur J Intern Med, 2020, 82. DOI: 10.1016/j.ejim.2020.09.002.
[40] 李晓强, 张福先, 王深明. 深静脉血栓形成的诊断和治疗指南(第三版)[J/OL]. 中国血管外科杂志:电子版, 2017, 9(4): 250-257.
[41] 蒋鹏, 刘建龙, 贾伟, 等. 《欧洲血管外科学会(ESVS)2021年静脉血栓管理临床实践指南》临床热点解读[J]. 中国普通外科杂志, 2022, 31(6): 717-727.
[42] STEVENS S M, WOLLER S C, KREUZIGER L B, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report[J]. Chest, 2021, 160(6): e545-e608.
[43] 植艳茹, 李海燕, 陆清声. 住院患者静脉血栓栓塞症预防护理与管理专家共识[J]. 解放军护理杂志, 2021, 38(6): 17-21.
[44] 上海市肺栓塞和深静脉血栓防治联盟, 国际血管联盟中国分部护理专业委员会, 上海市护理学会外科护理专业委员会, 等. 间歇充气加压用于静脉血栓栓塞症预防的中国专家共识[J]. 中华普通外科杂志, 2022, 37(7): 549-553.
[45] 吕丽琼, 彭仁梅, 刘化刚, 等. 深静脉血栓后综合征预防护理研究进展[J]. 护理学杂志, 2024, 39(19): 120-123.
[46] KEARON C, KAHN S R, AGNELLI G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)[J]. Chest, 2008, 133(6 Suppl):454S-545S.
[47] KEARON C, AKL E A, COMEROTA A J, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9 th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 142(2): e419s-e494s.
[48] KAHN S R, GALANAUD J P, VEDANTHAM S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome[J]. J Thromb Thrombolysis, 2016, 41(1): 144-153.